Last reviewed · How we verify
Vancomycin Continuous Infusion
At a glance
| Generic name | Vancomycin Continuous Infusion |
|---|---|
| Also known as | Vancocin, Continuous infusion |
| Sponsor | Aaron Cook |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis (NA)
- Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention (PHASE1)
- FMT for Lung and Associated-organ Rescue Efficacy in Pulmonary Infection With MDROs (NA)
- Continuous vs. Intermittent Infusion Vancomycin (PHASE4)
- A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients (PHASE1)
- A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis (PHASE3)
- Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin (PHASE4)
- Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |